Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller BJ, Gassama B, Sebastian D, Buckley P, Mellor A. Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects. Biological Psychiatry 2012, 73: 993-999. PMID: 23062357, PMCID: PMC3816144, DOI: 10.1016/j.biopsych.2012.09.007.Peer-Reviewed Original ResearchConceptsCD4/CD8 ratioFirst-episode psychosisAcute exacerbationAntipsychotic treatmentCD8 ratioClinical statusDrug-naĂŻve first-episode psychosisTrait markerImmune cell parametersState-related markersImmune system dysfunctionCross-sectional studyPotential confounding factorsLongitudinal studyMononuclear phagocytic systemMore longitudinal studiesLymphocyte abnormalitiesTotal lymphocytesClinical featuresAntipsychotic effectsAntipsychotic medicationSystem dysfunctionBlood lymphocytesInclusion criteriaReference lists80. Meta-analysis of monocytes and lymphocytes in schizophrenia: Clinical status and antipsychotic effects
Miller B, Gassama B, Sebastian D, Buckley P, Mellor A. 80. Meta-analysis of monocytes and lymphocytes in schizophrenia: Clinical status and antipsychotic effects. Brain Behavior And Immunity 2012, 26: s22-s23. DOI: 10.1016/j.bbi.2012.07.104.Peer-Reviewed Original ResearchFirst-episode psychosisAcute psychosisAntipsychotic treatmentCD4 levelsClinical statusTrait markerCD4/CD8 ratioImmune cell abnormalitiesImmune cell parametersState-related markersCD4/CD8Potential confounding factorsEffect sizeCD8 ratioImmune dysfunctionAntipsychotic effectsAntipsychotic medicationInclusion criteriaCell abnormalitiesReference listsStable outpatientsConfounding factorsPub MedState markerMajority of studies
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply